1. Public Population Project (P3G)

01 : Knoppers : Genetic Databases, International Collaboration and Secondary Uses 02 : Palmer : The Western Australian Genome Health Project 03 : van Duijn : Genome wide association studies of complex traits in outbred and isolated populations 04 : Burton : Size matters: the value of large scale genetic epidemiology

2. Genome Diversity

05 : Pääbo et al : Neandertal Genomics 06 : Clayton : Ethical Challenges in Exploring Genomic Diversity 07 : Adebamowo : Communities in Low-Resource Environments and Genetic Epidemiology Research 08 : Jin : Genome Diversity in the Asia-Pacific Region

3. Regulatory RNAs

09 : Wahlestedt : Regulatory natural antisense transcripts 10 : Harel-Bellan : Small non-coding RNAs to understand gene function 11 : Georges : Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease 12 : Mattick : The human genome as an RNA machine

4. Epigenomics

13 : Meaney : Maternal care, gene expression and epigenetic programming of the HPA stress response 14 : Beck : The Human Epigenome Project (HEP) 15 : Clark : Epigenetic Silencing in Cancer Cells 16 : Meehan et al : Non-catalytic roles for the maintenance methyltransferase, DNMT1, in development and disease

5. Genetics of Infectious Disease

17 : Schurr : Leprosy as a human model for the genetic study of common infectious diseases 18 : Tishkoff : Genetic Variation and Adaptation in Africa: Implications for Human Evolution and Disease 19 : Goodnow : Genetic pleiotropy and negative vs positive regulators of immune responses: analysis by chemically induced SNPs in inbred mice 20 : O'Brien : Genetic Architecture of Complex Infectious Diseases: Lessons from AIDS

6. Neuropsychiatric Genetics

21 : Porteous : The DISC1 pathway in psychosis, learning memory and mood 22 : Grant : Molecular circuitry of the synapse 23 : Geschwind : Autism: From Gene to Brain to Behavior 24 : Hayden : Proteolysis and Post-Translational Modifications of Huntingtin: Key Steps in the Pathogenesis of Huntington Disease

7. Pharmacogenomics

25 : Goodsaid : Pharmacogenomics at the FDA: Strategies That Work and Current Challenges 26 : Burke : Pharmacogenomics in Clinical Practice: Challenges and Opportunities 27 : Lindpaintner : Biomarkers and Medical Practice: Where do we stand? 28 : Phillips : Pharmacogenomics: Paving the Way to Improved Drug Development and Healthcare